Friday, July 10, 2026

pharma · Advanced Solid Tumor · Chronic Lymphocytic Leukemia

BEONE MEDICINES AUS

BEONE MEDICINES AUS is a pharma organization headquartered in Cambridge, USA. Primary therapeutic focus areas include Advanced Solid Tumor, Chronic Lymphocytic Leukemia, Solid Tumor, Adult, Mantle Cell Lymphoma, Previous

Cambridge, USA HQ
2010 Founded
3,177 Employees
TGA registrant Type
Company details
Clinical program

BG-89894

Phase 1 · small molecule · Advanced or Metastatic MTAP-deleted Solid Tumors

BG-89894 for Advanced or Metastatic MTAP-deleted Solid Tumors is a Phase 1 program (small_molecule) at BEONE MEDICINES AUS PTY LTD with 1 ClinicalTrials.gov record(s).

← All BEONE MEDICINES AUS PTY LTD projects Phase 1 small molecule terminated

Internal code BG-89894-101

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
BEONE MEDICINES AUS PTY LTD
Phase
Phase 1
Modality
small_molecule
Indication
Advanced or Metastatic MTAP-deleted Solid Tumors
Status
terminated
Trials
1

Clinical trials